Main Article Content
Abstract
Keywords
Article Details
-
Folia Medica Indonesiana is a scientific peer-reviewed article which freely available to be accessed, downloaded, and used for research purposes. Folia Medica Indonesiana (p-ISSN: 2541-1012; e-ISSN: 2528-2018) is licensed under a Creative Commons Attribution 4.0 International License. Manuscripts submitted to Folia Medica Indonesiana are published under the terms of the Creative Commons License. The terms of the license are:
Attribution ” You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial ” You may not use the material for commercial purposes.
ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions ” You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
You are free to :
Share ” copy and redistribute the material in any medium or format.
Adapt ” remix, transform, and build upon the material.
References
- Berge EO, Knappskog S, Geisler S, Staalesen V, Pacal M., Puntervol P, et al (2010). Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers. Mole. Cancer 9,173
- Bharadwaj AG, Kovar JL, Loughman E, Elowsky C, Oakley GG, Simpson MA (2009). Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and processing. Am J Pathol. 174,1027-36
- Blundell CD, Deangelis PL, Almond A (2006). Hyaluronan: the absence of amide-carboxylate hydrogen bonds and the chain conformation in aqueous solution are incompatible with stable secondary and tertiary structure models. Biochem J 396, 487-98
- Clark RA, Alon R, Springer TA (1996). CD44 and hyaluronan-dependent rolling interactions of lympho-cytes on tonsillar stroma. J Cell Biol. 134, 1075-87
- Evanko SP, Tammi MI, Tammi RH, Wight TN (2007). Hyaluronan-dependent pericellular matrix. Advanced Drug Delivery Reviews 59, 1352-1365
- Gadhoum Z, Delaunay J, Maquarre E, Durand L, Lancereaux V, Qi J, et al (2004). The Effect of anti-CD44 monoclonal antibodies on differentiation and proliferation of human acute myeloid leukemia cells. Leukemia & Lymphoma 45, 1501-1510
- Gao H, Yao Q, Lan X, Li S, Wu J, Zeng G, Xue Y (2016). Elevated HABP1 protein expression correlates with progression and poor survival in patients with gastric cancer. OncoTargets and Therapy 9, 6711-6718
- Ghatak S, Hascall VC, Karamanos NK, Markwald RR, Misra S (2012). Targeting the tumor microenvi-ronment in cancer progression. In Karamanos N, editor. Extracellular Matrix: Pathobiology and Signaling. Berlin, DeGruyter, p 729-46
- Jaime MC, Carol ST, and Garantziotis S (2015). Size matters: Molecular weight specificity of hyaluronan effects in cell biology. International Journal of Cell Biology
- Leach JB, Schmidt CE (2004). Hyaluronan. In: Bowlin GL, Wnek G. Encyclopedia of biomaterials and biomedical engineering. Informa Healthcare
- Lee JY, and Spicer AP (2000). Hyaluronan: a multifunctional, megadalton, stealth molecule. Current Opinion in Cell Biology 12, 581-586
- Li JH, Wang YC, Qin CD, et al (2016). Over expression of hyaluronan promotes progression of HCC via CD44-mediated pyruvate kinase M2 nuclear translocation. Am J Cancer Res 6, 509-21
- Liu S, Edgerton SM, Moore DH, Thor AD (2001). Measures of cell turnover (proliferation and apoptosis) and their association with survival in breast cancer. Clin Cancer Res 7, 1716-1723
- Lokeshwar VB and Selzer MG (2000). Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells. J Biol Chem 275, 27641-27649
- Louderbough JMV and Schroeder JA (2011). Understanding the Dual Nature of CD44 in Breast cancer Progression. Mol Cancer Res 9,12
- Marques ACF (2011). Investigation of The Effect of Structured Hyaluronic Acid Surfaces On Cell Proliferation and Expression of HA Cellular Receptors: CD44 and RHAMM. A thesis. Cranfield University.
- McKee T and McKee JR (2008). Biochemistry in Perspective: Carcinogenesis. In: Biochemistry: The Molecular Basis of Life. 4th Ed. USA, Oxford University Press
- Misra S, Hascall VC, Markwald RR, Ghatak S. 2015. Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer. Front Immunol 6, 201
- Murai T, Miyazaki Y, Nishinakamura H, Sugahara KN, Miyauchi T, Sako Y, et al (2004). Engagement of CD44 promotes Rac activation and CD44 cleavage during tumor cell migration. J Biol Chem 279, 4541-4550
- Naor D (2016). Editorial: Interaction Between Hyaluronic Acid and Its Receptors (CD44, RHAMM) Regulates the Activity of Inflammation and Cancer. Front Immunol 7, 39
- Noble PW (2002). Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biology 21, 25-29
- Patel S, Shaikh F, Devaraji V, Radadiya A, Shah K, Shah A, Rawal R (2017). Insights into the structural perturbations of spliced variants of CD44: a modeling and simulation approach. Journal of Biomolecular Structure and Dynamics 35, 354-367
- Posey JT, Soloway MS, Ekici S, Sofer M, Civantos F, Duncan RC, and Lokeshwar VB (2003). Evaluation of the Prognostic Potential of Hyaluronic Acid and Hyaluronidase (HYAL1) for prostate cancer. Cancer Research 63, 2638-2644
- Rangel MP, de Sá VK, Martins V, et al (2015). Tissue hyaluronan expression, as reflected in the sputum of lung cancer patients, is an indicator of malignancy. Braz J Med Biol Res. 48, 557-67
- Rössler A, Hinghofer-Szalkay H (2003). Hyaluronan fragments: an information-carrying system?. hypothesis. Hormone and Metabolic Research 35, 67-8
- Scott JE (1989). Secondary structures in hyaluronan solutions: chemical and biological implications. The Biology of Hyaluronan. Ciba Foundation Symposium 143, 6-14
- Siiskonen H (2013). Hyaluronan and hyaluronan synthases. A dissertation in Health Sciences. Kuopio, University of Eastern Finland
- Sitorus RS, Saukani G, Valk PVD (2009). The apoptosis paradox in retinoblastoma. Natural compounds and their role in apoptotic cell signaling pathways. Ann NY Acad Sci 1171, 77-86
- Soebagjo HD, Prastyani R, Sujuti H, Lyrawati D, Sumitro SB (2013). Profile of Retinoblastoma in East Java, Indonesia. World Journal of Medicine and Medical Science Research 1, 051-056
- Stern, R., A.A. Asari, and K.N. Sugahara. 2006. Hyaluronan fragments: An information-rich system. European J. Cell. Biol. 85, 699-715
- Tahmatzopoulos A, Papakonstantinou E, Kotakidou R, Hatzihristou D, Karakiulakis G (2012). Immunohistochemical expression of hyaluronic acid in the normal prostate, benign prostate hyperplasia and prostate carcinoma. Aristotle University Medical Journal 39, 1-6
- Toole BP (2002). Hyaluronan promotes the malignant phenotype. J Gly 12, 37R-42R
- Trihia H, Murray S, Price K, Gelber RD, Golouh R, Goldhirsch A, et al (2003). Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors--a surrogate marker? Cancer. 97, 1321-31
- Urbanska K, Sokolowska J, Szmidt M, Sysa P (2014). Proliferative and Apoptotic Activity of Glioblastoma Multiforme Cells Cultured on In Ovo Model. In Vivo 28, 541-548
- Voutilainen K, Anttila M, Sillanpää S, Tammi R, Tammi M, Saarikoski S, Kosma V (2003). Versican in epithelial ovarian cancer: relation to hyaluronan, clinicopathologic factors and prognosis 22, 103-15
- Wang W, Wu J, Zhang P, Fei X, Zong Y, Chen X, et al (2016). Prognostic and predictive value of Ki-67 in triple-negative breast cancer. Oncotarget 7, 31079-31087
- Wiranowska, M and Rojiani MV (2011). Extracellular Matrix Microenvironment in Glioma Progression, 12. Glioma - Exploring Its Biology and Practical Rele-vance, Dr. Anirban Ghosh (Ed.) InTech, p 257-284
References
Berge EO, Knappskog S, Geisler S, Staalesen V, Pacal M., Puntervol P, et al (2010). Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers. Mole. Cancer 9,173
Bharadwaj AG, Kovar JL, Loughman E, Elowsky C, Oakley GG, Simpson MA (2009). Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and processing. Am J Pathol. 174,1027-36
Blundell CD, Deangelis PL, Almond A (2006). Hyaluronan: the absence of amide-carboxylate hydrogen bonds and the chain conformation in aqueous solution are incompatible with stable secondary and tertiary structure models. Biochem J 396, 487-98
Clark RA, Alon R, Springer TA (1996). CD44 and hyaluronan-dependent rolling interactions of lympho-cytes on tonsillar stroma. J Cell Biol. 134, 1075-87
Evanko SP, Tammi MI, Tammi RH, Wight TN (2007). Hyaluronan-dependent pericellular matrix. Advanced Drug Delivery Reviews 59, 1352-1365
Gadhoum Z, Delaunay J, Maquarre E, Durand L, Lancereaux V, Qi J, et al (2004). The Effect of anti-CD44 monoclonal antibodies on differentiation and proliferation of human acute myeloid leukemia cells. Leukemia & Lymphoma 45, 1501-1510
Gao H, Yao Q, Lan X, Li S, Wu J, Zeng G, Xue Y (2016). Elevated HABP1 protein expression correlates with progression and poor survival in patients with gastric cancer. OncoTargets and Therapy 9, 6711-6718
Ghatak S, Hascall VC, Karamanos NK, Markwald RR, Misra S (2012). Targeting the tumor microenvi-ronment in cancer progression. In Karamanos N, editor. Extracellular Matrix: Pathobiology and Signaling. Berlin, DeGruyter, p 729-46
Jaime MC, Carol ST, and Garantziotis S (2015). Size matters: Molecular weight specificity of hyaluronan effects in cell biology. International Journal of Cell Biology
Leach JB, Schmidt CE (2004). Hyaluronan. In: Bowlin GL, Wnek G. Encyclopedia of biomaterials and biomedical engineering. Informa Healthcare
Lee JY, and Spicer AP (2000). Hyaluronan: a multifunctional, megadalton, stealth molecule. Current Opinion in Cell Biology 12, 581-586
Li JH, Wang YC, Qin CD, et al (2016). Over expression of hyaluronan promotes progression of HCC via CD44-mediated pyruvate kinase M2 nuclear translocation. Am J Cancer Res 6, 509-21
Liu S, Edgerton SM, Moore DH, Thor AD (2001). Measures of cell turnover (proliferation and apoptosis) and their association with survival in breast cancer. Clin Cancer Res 7, 1716-1723
Lokeshwar VB and Selzer MG (2000). Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells. J Biol Chem 275, 27641-27649
Louderbough JMV and Schroeder JA (2011). Understanding the Dual Nature of CD44 in Breast cancer Progression. Mol Cancer Res 9,12
Marques ACF (2011). Investigation of The Effect of Structured Hyaluronic Acid Surfaces On Cell Proliferation and Expression of HA Cellular Receptors: CD44 and RHAMM. A thesis. Cranfield University.
McKee T and McKee JR (2008). Biochemistry in Perspective: Carcinogenesis. In: Biochemistry: The Molecular Basis of Life. 4th Ed. USA, Oxford University Press
Misra S, Hascall VC, Markwald RR, Ghatak S. 2015. Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer. Front Immunol 6, 201
Murai T, Miyazaki Y, Nishinakamura H, Sugahara KN, Miyauchi T, Sako Y, et al (2004). Engagement of CD44 promotes Rac activation and CD44 cleavage during tumor cell migration. J Biol Chem 279, 4541-4550
Naor D (2016). Editorial: Interaction Between Hyaluronic Acid and Its Receptors (CD44, RHAMM) Regulates the Activity of Inflammation and Cancer. Front Immunol 7, 39
Noble PW (2002). Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biology 21, 25-29
Patel S, Shaikh F, Devaraji V, Radadiya A, Shah K, Shah A, Rawal R (2017). Insights into the structural perturbations of spliced variants of CD44: a modeling and simulation approach. Journal of Biomolecular Structure and Dynamics 35, 354-367
Posey JT, Soloway MS, Ekici S, Sofer M, Civantos F, Duncan RC, and Lokeshwar VB (2003). Evaluation of the Prognostic Potential of Hyaluronic Acid and Hyaluronidase (HYAL1) for prostate cancer. Cancer Research 63, 2638-2644
Rangel MP, de Sá VK, Martins V, et al (2015). Tissue hyaluronan expression, as reflected in the sputum of lung cancer patients, is an indicator of malignancy. Braz J Med Biol Res. 48, 557-67
Rössler A, Hinghofer-Szalkay H (2003). Hyaluronan fragments: an information-carrying system?. hypothesis. Hormone and Metabolic Research 35, 67-8
Scott JE (1989). Secondary structures in hyaluronan solutions: chemical and biological implications. The Biology of Hyaluronan. Ciba Foundation Symposium 143, 6-14
Siiskonen H (2013). Hyaluronan and hyaluronan synthases. A dissertation in Health Sciences. Kuopio, University of Eastern Finland
Sitorus RS, Saukani G, Valk PVD (2009). The apoptosis paradox in retinoblastoma. Natural compounds and their role in apoptotic cell signaling pathways. Ann NY Acad Sci 1171, 77-86
Soebagjo HD, Prastyani R, Sujuti H, Lyrawati D, Sumitro SB (2013). Profile of Retinoblastoma in East Java, Indonesia. World Journal of Medicine and Medical Science Research 1, 051-056
Stern, R., A.A. Asari, and K.N. Sugahara. 2006. Hyaluronan fragments: An information-rich system. European J. Cell. Biol. 85, 699-715
Tahmatzopoulos A, Papakonstantinou E, Kotakidou R, Hatzihristou D, Karakiulakis G (2012). Immunohistochemical expression of hyaluronic acid in the normal prostate, benign prostate hyperplasia and prostate carcinoma. Aristotle University Medical Journal 39, 1-6
Toole BP (2002). Hyaluronan promotes the malignant phenotype. J Gly 12, 37R-42R
Trihia H, Murray S, Price K, Gelber RD, Golouh R, Goldhirsch A, et al (2003). Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors--a surrogate marker? Cancer. 97, 1321-31
Urbanska K, Sokolowska J, Szmidt M, Sysa P (2014). Proliferative and Apoptotic Activity of Glioblastoma Multiforme Cells Cultured on In Ovo Model. In Vivo 28, 541-548
Voutilainen K, Anttila M, Sillanpää S, Tammi R, Tammi M, Saarikoski S, Kosma V (2003). Versican in epithelial ovarian cancer: relation to hyaluronan, clinicopathologic factors and prognosis 22, 103-15
Wang W, Wu J, Zhang P, Fei X, Zong Y, Chen X, et al (2016). Prognostic and predictive value of Ki-67 in triple-negative breast cancer. Oncotarget 7, 31079-31087
Wiranowska, M and Rojiani MV (2011). Extracellular Matrix Microenvironment in Glioma Progression, 12. Glioma - Exploring Its Biology and Practical Rele-vance, Dr. Anirban Ghosh (Ed.) InTech, p 257-284